ARTICLE | Company News
Arakis, Vectura Ltd. deal
December 4, 2000 8:00 AM UTC
Vectura will formulate Arakis' AD 237 as an inhaled medication , and the companies will develop the compound as a long acting bronchodilator to treat chronic obstructive pulmonary disease (COPD). The...